Table 1.
Summary of characteristics for 48 subjects with mild COVID-19 and 42 healthy controls
| Characteristic | Subjects with mild COVID-19 (n=48) | Healthy controls (n=42) |
|---|---|---|
| Age, median (IQR), years | 39 (29-51) | 34 (29-46) |
| Sex, n (%) | ||
| Male | 12 (25) | 13 (31) |
| Female | 36 (75) | 29 (69) |
| Ethnicity, n (%) | ||
| Caucasian | 48 (100) | 40 (95) |
| Hispanic | 1 (2•5) | |
| Middle Eastern | 1 (2•5) | |
| Infection confirmation, n positive (%) | ||
| Diagnostic PCR test | 45 (94) | |
| Diagnostic antibody test | 3 (6) | |
| WANTAI test | 48 (100) | 1 (2•5)# |
| Duration of symptoms, median (IQR), days | 14 (8-16) | |
| Baseline timepoint, median (IQR), days | 49 (29-86) | |
| 6-month timepoint, median (IQR), days | 186 (182-192) | |
| Days between timepoints, median (IQR), days | 127 (101-154) | |
| Symptoms, n (%) | ||
| Fatigue | 35 (73) | |
| Fever | 34 (71) | |
| Headache | 32 (67) | |
| Myalgia | 30 (63) | |
| Cough | 28 (58) | |
| Sore throat | 20 (42) | |
| Joint pain | 20 (42) | |
| Shortness of breath | 18 (38) | |
| Nasal congestion | 17 (35) | |
| Anosmia | 17 (35) | |
| Chest pain | 11 (23) | |
| Diarrhoea | 7 (15) | |
| Vomiting/Nausea | 2 (4) | |
| Total number of symptoms, median (IQR) | 5 (4-8) | |
| Transmission route, n (%) | ||
| Exposure at work | 26 (55) | |
| Unknown | 8 (17) | |
| Social activity | 5 (10) | |
| Choir activity | 5 (10) | |
| Household member | 4 (8) |
#
Excluded from further analysis (H-40).